FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries buPROPion Hydrochloride Extended-Release Recall

buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, D…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
Dec 13, 2023
Recall ID
D-0137-2024
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled buPROPion Hydrochloride Extended-Release starting Nov 22, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0137-2024 on Dec 13, 2023. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-738-86

Lot numbers, UPCs & expiration codes

Lot HAD0630A, exp 1/2024

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0137-2024
Classification
Class III
Status
Terminated
Recall initiated
Nov 22, 2023
FDA report date
Dec 13, 2023
Quantity
2016 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0137-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
93472
Address
2 Independence Way
Code information
Lot HAD0630A, exp 1/2024
Postal code
08540-6620
Report date
Dec 13, 2023
Product type
Drugs
Recall number
D-0137-2024
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
2016 Bottles
Termination date
Jun 27, 2024
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-738-86
Distribution pattern
Nationwide
Recall initiation date
Nov 22, 2023
Initial firm notification
Letter
Center classification date
Dec 1, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0137-2024, published Dec 13, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls